Clinical Trials Logo

Rheumatic Diseases clinical trials

View clinical trials related to Rheumatic Diseases.

Filter by:

NCT ID: NCT04616118 Completed - Cardiac Disease Clinical Trials

Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)

Start date: May 27, 2020
Phase: N/A
Study type: Interventional

Given the current public health crisis the use of telehealth consultation visits including phone-only and video visits has exponentially increased. This study will investigate if the conduct of telehealth phone only visits is non-inferior in terms of patient satisfaction/experience, adherence to post-visit recommendations such as medications, blood work and other medical testing, follow up care, when compared to the conduct of video delivered telehealth visits. Patients will be randomized to receive a routine care visit via phone only vs. video.

NCT ID: NCT04568421 Completed - Rheumatic Diseases Clinical Trials

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

SAR-COVID
Start date: August 18, 2020
Phase:
Study type: Observational [Patient Registry]

SAR-COVID is a national, multicenter, prospective, observational longitudinal registry of consecutive patients with diagnosis of rheumatic diseases treated or not with immunomodulatory and/or immunosuppressive drugs and SARS-CoV-2 infection (asymptomatic or COVID-19). Hypothesis: Patients with rheumatic diseases who are under chronic treatment with immunomodulatory and/or immunosuppressive drugs more frequently have an asymptomatic infection, a milder COVID-19 and lower mortality than patients with rheumatic diseases without immunomodulatory and/or immunosuppressive treatments.

NCT ID: NCT04557358 Completed - Clinical trials for Rheumatoid Arthritis

Impact in the Medical Care Among the Rheumatic Diseases Patients in a Hospital in México During COVID-19 Pandemic

Start date: October 1, 2020
Phase:
Study type: Observational

The National Institute of Medical Sciences and Nutrition is a national reference center for rheumatic diseases that belongs to The National Institutes of Health, and has Federal founding. More than 8,000 patients with a wide variety of rheumatologic diagnosis receive medical care. On March 2020, the WHO announced COVID-19 outbreak a pandemic. The first case was registered in Mexico on February 2020. In March 2020, the Mexican Government requested that our Institution should restrict health care to exclusively COVID-19 patients; accordingly, outpatient consultations were, and up to August 2020 still, hold on. Meanwhile, when possible, the Department of Immunology and Rheumatology has implemented an "on-demand", non-organized patient´s health care, through email and phone contact; nonetheless, and due to the middle-low socioeconomic status of most of our patients and limited technical resources available at our Institution, the attempt has been challenging.

NCT ID: NCT04542031 Completed - Covid19 Clinical Trials

COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL

CRISP
Start date: December 14, 2020
Phase: N/A
Study type: Interventional

The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology of COVID-19 in the rheumatological population is largely unknown large case registries are beginning to show potential drug treatment interactions. Strict self-isolation (shielding) has been recommended for those deemed 'high risk' although its impact on the likelihood of COVID-19 infection and health related quality of life (HRQoL) is unclear. The study aims to explore how this unprecedented situation has impacted the Trust patients primarily evaluating prevalence of the infection, effect of stringent social distancing (shielding) and Quality of Life (QOL). This will be done via a voluntary questionnaire, sent via text messaging at 6 and 12 months.

NCT ID: NCT04530682 Completed - Clinical trials for Chronic Inflammatory Rheumatism

COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

COVIDRIC-2
Start date: March 5, 2021
Phase:
Study type: Observational

Accurate knowledge of the humoral immune responses induced by SARS-CoV-2 in patients undergoing immunosuppressive therapy is essential to guide recommendations for infected patients and for vaccination policy for uninfected immunosuppressed patients.

NCT ID: NCT04481984 Completed - Rehabilitation Clinical Trials

Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis

Start date: July 15, 2016
Phase: N/A
Study type: Interventional

Systemic sclerosis (SSc) is a heterogeneous autoimmune disease characterized by fibrosis of the skin and internal organs. Hand involvement is one of the most observed musculoskeletal involvements in patients with SSc, which can impact on general health, quality of life, and psychological status. Hand exercise programs can help patients to improve not only hand function but also general health status; nevertheless, further randomized control trials (RCTs) are needed to clarify its effect. Hence, the investigators aimed to investigate the effectiveness of home-based, self-administered exercise program for hands in patients with SSc and demonstrate the improvements in general health status.

NCT ID: NCT04426513 Completed - Clinical trials for Rheumatoid Arthritis

Magnetotherapy in Rheumatoid Arthritis Treatment

Start date: May 20, 2020
Phase: N/A
Study type: Interventional

Participants with rheumatoid arthritis with recommendation to physiotherapy. Created 3 study groups: 1. Only kinesiotherapy 2. Kinesiotherapy with unipolar magnetic field 3. Kinesiotherapy with bipolar magnetic field Kinesiotherapy with magnetic field give better effects than only kinesiotherapy.

NCT ID: NCT04407299 Completed - COVID Clinical Trials

COVID-19 Impact on Rheumatic Patients

Start date: April 20, 2020
Phase:
Study type: Observational

A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.

NCT ID: NCT04398381 Completed - Intensive Care Unit Clinical Trials

Prognosis of SRD Patients in the ICU

ProSyDICU
Start date: March 1, 2017
Phase:
Study type: Observational

Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality and most importantly long-term outcome are scarce. The aim of this study is to assess short and long-term outcome of patients with SRD admitted to the ICU in a retrospective cohort study (2006 - 2016).

NCT ID: NCT04397107 Completed - Clinical trials for Systemic Lupus Erythematosus

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases

SLE,pSS,JIA
Start date: August 15, 2020
Phase: N/A
Study type: Interventional

The study aims to explore the therapeutic value and mechanism of Interleukin-2 on children with rheumatic diseases (Systemic Lupus Erythematosus, Primary Sjögren Syndrome, Juvenile Idiopathic Arthritis).